Business Wire

Delivering the Future: FedEx Unveils Autonomous Delivery Robot

Del

FedEx Corp. (NYSE:FDX) announced today a development in cutting-edge delivery solutions to meet the rapidly changing needs of consumers — the FedEx SameDay Bot — an autonomous delivery device designed to help retailers make same-day and last-mile deliveries to their customers.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190227005421/en/

FedEx SameDay Bot (Photo: Business Wire)

FedEx SameDay Bot (Photo: Business Wire)

With the bot, retailers will be able to accept orders from nearby customers and deliver them by bot directly to customers’ homes or businesses the same day. FedEx is collaborating with companies such as AutoZone, Lowe’s, Pizza Hut, Target, Walgreens and Walmart to help assess retailers’ autonomous delivery needs. On average, more than 60 percent of merchants’ customers live within three miles of a store location, demonstrating the opportunity for on-demand, hyper-local delivery.

“The FedEx SameDay Bot is an innovation designed to change the face of local delivery and help retailers efficiently address their customers’ rising expectations,” said Brie Carere, executive vice president and chief marketing and communications officer for FedEx. “The bot represents a milestone in our ongoing mission to solve the complexities and expense of same-day, last-mile delivery for the growing e-commerce market in a manner that is safe and environmentally friendly.”

The FedEx bot is being developed in collaboration with DEKA Development & Research Corp. and its founder Dean Kamen, inventor of many life-changing technologies, including the iBot™ Personal Mobility Device and the Segway®.

“The bot has unique capabilities that make it unlike other autonomous vehicles,” Kamen said. “We built upon the power base of the iBot, an advanced, FDA-approved, mobility device for the disabled population with more than 10 million hours of reliable, real-world operation. By leveraging this base in an additional application, we hope that the iBot will become even more accessible to those who need it for their own mobility.”

The FedEx bot is designed to travel on sidewalks and along roadsides, safely delivering smaller shipments to customers’ homes and businesses. Bot features include pedestrian-safe technology from the iBot, plus advanced technology such as LiDAR and multiple cameras, allowing the zero-emission, battery-powered bot to be aware of its surroundings. These features are coupled with machine-learning algorithms to detect and avoid obstacles, plot a safe path and allow the bot to follow road and safety rules. Proprietary technology makes the bot highly capable, allowing it to navigate unpaved surfaces, curbs, and even steps for an extraordinary door-to-door delivery experience.

FedEx plans to test the bot this summer in select markets, including Memphis, Tenn., pending final city approvals.

“We couldn’t be more excited that FedEx chose its hometown as one of the pilot cities for this revolutionary innovation,” Mayor Jim Strickland, City of Memphis, said. “We look forward to working with FedEx to continue introducing technologies that will help improve the quality of life in our community.”

The initial test will involve deliveries between selected FedEx Office locations. FedEx Office currently offers a SameDay City service that operates in 32 markets and 1,900 cities using branded FedEx vehicles and uniformed FedEx employees. The FedEx bot will complement the FedEx SameDay City service.

“The FedEx SameDay Bot represents the next chapter in our long legacy of delivering innovation and outstanding service, supported by an already existing FedEx logistics ecosystem,” said Brian Philips, President and CEO of FedEx Office. “We are excited to bring this technology to address new markets and better support our customers. The companies who have provided feedback on its potential use have been instrumental in ensuring we are looking toward the future of e-commerce.”

The FedEx bot will support retailers in several segments, and the first group of retail customers to view the prototype have recognized the value the technology can bring to their industries.

“We are thrilled to be working with the talented teams at FedEx and DEKA on this revolutionary innovation,” said Bill Rhodes, Chairman, President and CEO, Customer Satisfaction, AutoZone. “When we saw the FedEx SameDay Bot in action, it confirmed to our team the many ways it can help us improve our service by offering reliable, highly efficient deliveries to our customers.”

“The convenience and capability of the FedEx Same Day Bot has the potential to greatly simplify and speed distribution for the full range of our customers. Consider pros who could save time and money by never leaving the job site for the critical tools and supplies they need from Lowe’s,” said Don Frieson, Lowe’s Executive Vice President, Supply Chain. “We look forward to exploring all the possibilities to enhance the service we provide our customers through this innovation.”

“Pizza Hut is constantly exploring new technology-based solutions to advance our delivery business as we look to redefine the modern pizza experience for our customers,” said Nicolas Burquier, chief customer and operations officer, Pizza Hut, U.S. “The opportunity to work with a proven innovator in the delivery space like FedEx allows us the opportunity to leverage cutting-edge technology to further optimize our best-in-class delivery experience.”

“We continue to invest in new technologies and capabilities that make Target the easiest place to shop – both now and in the future. We’re excited to be collaborating with FedEx to explore how autonomous robots could enhance delivery services and more, ensuring we continue to exceed our guests’ expectations for ease and convenience,” said John Mulligan, chief operating officer, Target.

“At Walgreens, we’re on a journey to leverage the latest in innovative technologies to provide a differentiated pharmacy and health care experience, and delivery solutions that bring our services to our customers wherever they are and whenever they need them,” said Alex Gourlay, co-chief operating officer, Walgreens Boots Alliance, Inc. “With FedEx as a partner, Walgreens has become the fastest choice for next-day prescription delivery in the U.S., and we’re excited that through our growing relationship, the FedEx SameDay Bot is another way we can offer better service and greater convenience to our customers.”

The bot made its first public appearance during NBC’s The Tonight Show Starring Jimmy Fallon on Tuesday, Feb. 26. This prototype will be refined to meet safety standards and regulations, and the specific needs of customers. For more information on the FedEx SameDay Bot, please visit thefuturefedex.com. For b-roll, please click here.

About FedEx Corp.

FedEx Corp. (NYSE:FDX) provides customers and businesses worldwide with a broad portfolio of transportation, e-commerce and business services. With annual revenues of $69 billion, the company offers integrated business applications through operating companies competing collectively and managed collaboratively, under the respected FedEx brand. Consistently ranked among the world’s most admired and trusted employers, FedEx inspires its more than 450,000 team members to remain “absolutely, positively” focused on safety, the highest ethical and professional standards and the needs of their customers and communities. To learn more about how FedEx connects people and possibilities around the world, please visit about.fedex.com.

About DEKA Research & Development Corp.

Based in Manchester, NH, DEKA is a research and development company of nearly 600 employees comprised of engineering, manufacturing and quality assurance professionals focused on the development of new technologies that span a diverse set of applications. The company was founded in 1982 by Dean Kamen, an inventor who holds more than a thousand U.S. and foreign patents and numerous awards, many of them for innovative medical devices that have expanded the frontiers of healthcare worldwide.

Certain statements in this press release may be considered forward-looking statements, such as management’s expectations regarding the capabilities of and efficiencies available through the FedEx SameDay Bot, and our ability to satisfy applicable safety standards and regulations and receive required government approvals. Such forward-looking statements are subject to risks, uncertainties and other factors, including inherent uncertainty that accompanies new and innovative technology, unexpected results from the initial tests, and evolving safety standards, regulations and required government approvals, which could cause actual results to differ from results expressed or implied by such forward-looking statements. Any forward-looking statement speaks only as of the date on which it is made. We do not undertake or assume any obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

Contact information

Bonny Harrison
FedEx Media Relations
901.434.5207
bonny.harrison@fedex.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Abzena Announces New Fully Integrated Developability and Optimization Service to Improve Lead Selection and De-risk Biologic Cell Line Development21.3.2019 13:44:00 CETPressemelding

Abzena, the leading biologics target to GMP partner research organisation (PRO), announced its Cambridge UK site has brought together its extensive discovery, immunogenicity assessment, protein engineering, formulation, bioassay and analytical expertise to launch a developability assessment and optimization service to assist customers in selecting and developing the best lead candidate to take forward for manufacture. The new Developability Service reduces the time, risk and cost required to take multiple lead candidates through cell line development and manufacturing. Biologics have potential liabilities for safety, functionality, stability and scalability and when these issues are identified early alternate leads can be selected, liabilities engineered out or measures can be taken to mitigate risk. The Developability Service also enables the selection of drug candidates most aligned with the target product profile by evaluating a range of functionality and specificity readouts. The s

XPRIZE Identifies 10 Future Breakthroughs Required to Protect Our Forests21.3.2019 13:27:00 CETPressemelding

Today, on the United Nations’ International Day of Forests, XPRIZE is releasing the Future of Forests Impact Roadmap, created in partnership with Kimberly-Clark Corporation. The digital report and its interactive website, based on future foresight techniques, illustrate the breakthroughs required for a healthier forest ecosystem, which might be the basis of future XPRIZE competitions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190321005409/en/ Across the world, forests provide food security and shelter, protect biodiversity and house indigenous populations. While forests cover more than 30 percent of the Earth’s surface, more than 32 million acres of forests are lost due to human activity every year, with research showing that continued mass deforestation and degradation is accelerating climate change. XPRIZE designs and operates global competitions to incentivize the development of technological breakthroughs that accel

Mark Thorne Joins BCW as Global Chief Financial Officer and Chief Operating Officer21.3.2019 13:17:00 CETPressemelding

BCW (Burson Cohn & Wolfe), a leading global communications agency, announced today that Mark Thorne has been appointed Global Chief Financial Officer and Chief Operating Officer, effective immediately. Thorne will be a strategic partner to BCW Global CEO Donna Imperato in transforming the agency’s financial model to better reflect its wide range of services and offerings. He is based in New York and replaces Pat Przybyski, formerly Global Chief Financial Officer. “Mark is well known for his strong business acumen, deep operational experience and high-level strategic thinking,” said Imperato. “I have known Mark for many years and am thrilled to now call him my partner. He is the right leader to help BCW execute our strategies and grow exponentially.” Thorne spent the past 20 plus years with Hill+Knowlton Strategies in a range of leadership roles, most recently serving as Global Chief Financial Officer and Global Chief Operating Officer. Prior to that, Thorne was Executive Vice President

Imago BioSciences Announces $40 Million Series B Financing Led by Omega Funds21.3.2019 13:09:00 CETPressemelding

Imago BioSciences, Inc., a clinical-stage biotechnology company developing innovative treatments for myeloid diseases, today announced a $40 million Series B financing led by Omega Funds, a leading international investment firm that creates and invests in life sciences companies. Other investors participating in the round include existing investors Frazier Healthcare Partners, Amgen Ventures, and MRL Ventures Fund as well as HighLight Capital, Pharmaron and Greenspring Associates. Dr. Dina Chaya from Omega Funds will join the board of directors and Dennis Henner will remain Chairman of the Board, representing his fund. “Imago BioSciences is extremely gratified with the interest and support of the investment community; we are particularly pleased with the composition of this new investment syndicate,” said Hugh Young Rienhoff, Jr. M.D., CEO at Imago BioSciences. “These funds will enable Imago to advance our programs through the completion of Phase 2b studies.” “We are excited to work wi

Workiva Wins DevOps Excellence Award in London21.3.2019 13:03:00 CETPressemelding

Workiva (NYSE:WK), the leading cloud provider of connected data, reporting and compliance solutions, today announced that its Wdesk platform was named the Best Software-Defined Product, last night at Computing's DevOps Excellence Awards dinner. The Computing DevOps Excellence Awards recognize outstanding achievement from organisations, personalities and solutions operating within the DevOps industry. Winners were selected on their superior functionality, level of ability to modernize business processes, positive customer feedback and a strong return on investment. “We are proud to win this prestigious award,” said Marty Vanderploeg, CEO of Workiva. “As the global leader in connected reporting, XBRL and Inline XBRL, our Wdesk platform helps customers all over the world consolidate, connect and tag their data in a single, cloud environment so they are able to reduce risk and save time when filing reports with various regulators and other stakeholders.” XBRL (eXtensible Business Reporting

Teleflex Announces Real-World Data Demonstrating the Effectiveness of the UroLift® System to Treat Patients with Enlarged Prostate21.3.2019 11:30:00 CETPressemelding

Teleflex Incorporated (NYSE:TFX) today announced that multiple studies were presented at the 2019 European Association of Urology (EAU) meeting in Barcelona, Spain, highlighting the effectiveness of the UroLift® System, a minimally invasive treatment, usually performed in-office that provides rapid relief and recovery from the symptoms of benign prostatic hyperplasia (BPH).1,2 BPH, also known as enlarged prostate, is a common condition marked by bothersome urinary symptoms that can cause loss of productivity, depression, interrupted sleep, and decreased quality of life.3 BPH affects over 40 million men in the United States alone.4 If left untreated, the condition can worsen over time and cause permanent bladder damage.5 A presentation entitled Pulling The Foley: Can the Prostatic Urethral Lift be used in men with catheter-dependent urinary retention? was presented by Thomas Mueller, M.D., urologist of New Jersey Urology (Voorhees, N.J.). The study highlighted real-world retrospective d